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Summary
Introduction: Human papillomavirus (HPV) is recognized as a major causative agent for cervical
carcinomas. Based on their oncogenic potential, HPV subtypes have been divided into high- and
low-risk. In Pakistan, screening for HPV in female patients is not commonly practiced, and as a
consequence, the degree of HPV prevalence and its correlation with cervical cancer is unknown.
Objective: In this study, we have attempted to estimate the prevalence of HPV infection, and
also the HPV subtype profile, among Pakistani women with cervical cancer from varied geo-
graphical, racial, and social backgrounds within Pakistan.
Methodology: Women visiting two tertiary care hospitals in Karachi, diagnosed with carcinoma of
the cervix within the past 15 years, were analyzed for HPV subtypes in their cancer specimens.
Retrospectively, 60 paraffin-embedded cervical cancer biopsies were examined for the presence
of HPV DNA. After DNA extraction from these samples, polymerase chain reaction (PCR) was used
to amplify the HPV L1 gene using the consensus (general) primers, and primers specific for
subtypes 16 and 18.
Results: Of the 60 samples analyzed, only one sample was HPV negative; the rest of the samples
were positive for the presence of HPV. Of the 59 HPV positive samples, 56 showed the presence of
HPV16andone samplewaspositive forHPV18;HPVsubtypecouldnotbedetermined in two samples.
Conclusion: Our results show a strong relationship between HPV infection and cervical cancer
among Pakistani women. These results underscore the need to implement regular HPV screening
for Pakistani women. An early diagnosis of HPV infection will allow better health management to
reduce the risk of developing cervical cancer.
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The human papillomavirus (HPV) is one of the most common
sexually transmitted viruses among men and women in Wes-
tern countries.1 The link between HPV infection and the
development of pre-cancerous cervical, anal, and genital
lesions, as well as cervical, anal, and genital cancers, is well
established.2 There are over 100 different subtypes of HPV,
which are distinguished by variations in their genetic
sequence.2,3 On the basis of their oncogenic potential,
HPV subtypes are classified into high- and low-risk.4—6 Infec-
tion with high-risk HPV genotypes leads to an increased risk of
cervical carcinoma. Among the HPV subtypes that infect the
anogenital tract, subtypes 16, 18, 31, 33, 35, 39, 45, 51, 52,
56, 58, 66, and 69 have been defined as high-risk for cervical
carcinoma.2,3 These HPV subtypes are commonly found in
anogenital cancers but typically do not cause noticeable
warts; as a result, HPV infection may go undetected.4—6
Cervical cancer is the second most common malignancy in
women worldwide, and it remains a leading cause of cancer-
related death for women in developing countries. Under the
best medical facilities, at least 37.5% of the diagnosed
patients die from their disease each year. This represents
2% of all cancer deaths and 18% of deaths from gynecological
cancers.7 Cervical carcinoma is more common in Hispanic,
African American, and Native American women than in Cau-
casian women.3 In the USA, it is the fourth most common
malignant neoplasm in women, after carcinoma of the
breast, colorectum, and endometrium. The incidence of
invasive cervical cancer has declined steadily in the USA
over the past few decades; however, it continues to rise in
many developing countries. The change in the epidemiolo-
gical trend has been attributed to mass screening with
Papanicolaou (Pap) smears,8 with the help of which
500 000 new cases are diagnosed each year internationally.
In Pakistan, HPV screening is not commonly practiced.
Additionally, risk factors and modes of transmission for HPV
among Pakistani women have not been adequately evalu-
ated. A major barrier in establishing the epidemiology of HPV
in this country is the social taboo on all matters pertaining to
sex, including sexually transmitted infections (STIs). These
socio-cultural prohibitions create a substantial barrier to the
investigation of issues concerning STIs. As a result, there are
no or very little data available to quantify the burden of HPV
and HPV-associated cervical carcinoma in Pakistan.9
Thepresent studywas carried out as a first step towards the
compilation ofHPVepidemiology in Pakistan. The intent of this
work was to seek a potential relationship between HPV infec-
tion and the occurrence of cervical carcinoma. Furthermore,
subtyping for certain high-risk HPV subtypes was performed to
determine which were common among Pakistani women.
Materials and methods
Sample collection
A total of 60 formalin-fixed paraffin-embedded samples of
cervical biopsies were collected from tertiary care hospitals
in Karachi, Pakistan, namely, the Aga Khan and Civil Hospi-
tals. The biopsies were obtained during the period of January
1991 to June 2005. The samples were from female patientsaged 20 to 60 years, already diagnosed with squamous or
adenocarcinoma of the cervix. These patients visited the Aga
Khan and Civil Hospitals from various parts of the country,
and represented wide social and economical strata, diverse
ethnicities, and varied genetic backgrounds.
Slides of all biopsy samples were reviewed by an expert
histopathologist to confirm the diagnosis. Informed consent
was obtained from patients for the use of their samples for
research purposes.
DNA extraction
For DNA extraction from paraffin-embedded tissue, the
methods of Baay et al. and Mikaelsdottir et al.10,11 were
adopted for our experiments. To increase DNA yield and
quality, the extraction procedure was modified as follows:
3—5-mm sections of paraffin-embedded cervical carcinoma
tissue were cut on a microtome and tissues were deparaffi-
nized with xylenes. Washes of 100% ethanol were used to
remove traces of xylenes from the tissue. After the traces of
ethanol were removed by air-drying, the tissue was homo-
genized and the following were added: 20 mL 20% SDS, 80 mL
protein kinase buffer (0.375 M NaCl, 0.12 M EDTA, pH 8.0),
and 40 mL of proteinase K (10 mg/mL); sterile water was
added to a final volume of 380 mL. Themixture was incubated
at 55 8C overnight to allow digestion by proteinase K.
The followingmorning, 100 mL of 6 MNaClwas added to the
sample. The protein precipitate was removed by centrifuga-
tion for 5 min at 13 000 rpm, and the supernatant was trans-
ferred to a fresh tube. To precipitate the DNA, 1 mL of 100%
ethanol was then added to the sample. The sample was
centrifuged at 13 000 rpm for 5 min, and the DNA pellet
obtained was washed with 70% ethanol and air-dried. The
pellet was then resuspended in 50 mL of 1 TE (10 mM Tris-
Cl, pH 8.0, 1 mM EDTA) buffer and stored at 20 8C until
further use.
Polymerase chain reaction (PCR)
The samples were analyzed by PCR using four sets of primers,
i.e., GP5/GP6, general primers for HPV; TS16-A/TS16-B and
TS18-A/TS-18B, subtype-specific primers for HPV subtypes 16
and 18, respectively;10 and PC03/PC04 for b-globin.11
Sequences for the primers are given in Table 1, along with
the length of respective PCR amplimers and the targeted
gene. The PCR conditions for these primers were as follows.
For primers GP5/GP6, the total 25 mL PCR reaction mix-
ture contained 5 mL sample, 10 mM Tris-HCl, pH 9.0, 50 mM
KCl, 0.1% Triton X-100, 1 mM MgCl2, 200 mM deoxynucleotide
triphosphates (dNTPs), 0.4 pmol of each primer, and 0.2 U of
Taq polymerase. The PCR thermal profile was: 95 8C for
5 min, and 40 cycles of 94 8C for 30 s, 45 8C for 30 s, 72 8C
for 30 s, and final extension of 5 min at 72 8C.
PCR conditions for TS-16 and TS-18 primers were the same
as for the GP primers, except that for TS-16 and TS-18 the
annealing temperatures were 61 8C and 63 8C, respectively.
For PC03/PC04 primers, the total 25 mL PCR reaction mix-
ture contained 5 mL sample, 10 mM Tris-HCl, pH 9.0, 50 mM
KCl, 0.1%Triton X-100, 1 mMMgCl2, 200 mMdNTPs, 0.2 pmol of
each primer, and 0.2 U of Taq polymerase. The PCR thermal
profilewas 94 8C for 5 min, and 40 cycles of 94 8C for 30 s, 51 8C
for 30 s, 72 8C for 30 s, and 5 min final extension at 72 8C.
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Figure 1 Representative gel of HPV PCR. Lanes 1—14 show the
50 bp molecular weight ladder. Lanes 2—5 are results from a
cervical carcinoma (CC) specimen. PCR primers used: b-globin,
lane 2; HPV (general primers), lane 3; HPV subtype 16, lane 4;
HPV subtype 18, lane 5. Lanes 6—9 are positive controls for HPV,
HPV16, and HPV18; primer order is the same as for lanes 2—5.
Lanes 10—13 are negative controls for HPV, HPV16, and HPV18;
primer order is the same as for lanes 2—5. Negative and positive
controls are described in the Materials and methods section. The
cervical carcinoma specimen is positive for b-globin, HPV, and
HPV16, but negative for HPV18. The positive control has
expected amplimers in all four lanes. The negative control shows
no amplification by HPV, HPV16, or HPV18 primers; a positive
band is observed, however, for b-globin gene.
Table 1 Primers used for HPV typing
Primer Sequence Target gene Amplimer length
GP5 TTTGTTACTGTGGTAGATAC L1 155 bp
GP6 GAAAAATAAACTGTAAATCA
TS16-A GGTCGGTGGACCGGTCGATG L1 96 bp
TS16-B GCAATGTAGGTGTATCTCCA
TS18-A CCTTGGACGTAAATTTTTGG L1 115 bp
TS18-B CACGCACACGCTTGGCAGGT
PC03 ACACAACTGTGTTCACTAGC b-Globin 110 bp
PC04 CAACTTCATCCACGTTCACC
References for each primer are cited in the Materials and methods section. GP, general primer for L1 HPV; TS, type-specific primers for L1
HPV; PC0, primers for b-globin gene.Amplified PCR product was run on 2% agarose gel and
stained with ethidium bromide. The PCR products were
identified on the basis of their predicted fragment size.
To authenticate our results, several controls were used in
the study: (a) To validate the PCR data, DNA from positive
control tissues, i.e., cervical carcinoma samples known to be
positive for HPV subtype 16 or 18, was subjected to PCR. (b)
To confirm successful DNA extraction, PC03/PC04 primers
were used to amplify b-globin gene. (c) Negative PCR con-
trols were included without DNA template to control for
template contamination. (d) To control for DNA contamina-
tion during sample preparation, HPV-negative control tissue
was processed on the microtome along with the cervical
carcinoma samples. The entire batch of these samples,
including the negative control tissue, was subjected to
DNA extraction and then to PCR in a single session.
Results
We estimated the prevalence of HPV in 60 cervical carcinoma
biopsies from Pakistani patients coming from diverse cul-
tural, social, and economic strata. Our results showed 59 of
the samples to be positive for HPV. The subtype found in 57 of
the 60 samples was HPV16, whereas HPV18 was detected in
only one sample.
Discussion
The study reported here is the first of its kind to gain an
understanding of the prevalence of HPV in Pakistani patients
with cervical carcinoma. The work was performed retro-
spectively, using paraffin-embedded cervical carcinoma
biopsies taken from 1991 to 2005, from two different hospi-
tals in Karachi. The hospitals approached for this study, Aga
Khan University Hospital and Civil Hospital, are two of the
major healthcare centers in Pakistan, where patients from all
walks of life are received for treatment. To ensure that the
patients for this study were chosen from a diverse back-
ground, the only selection criteria used for the patients was
gender (female) and cancer diagnosis (positive). In other
words, no distinction was made on the basis of ethnic, social,
or economic background. Furthermore, no distinction was
made between the types of cervical carcinoma either; squa-
mous as well as adenocarcinomas were included in this study.
All samples were screened for HPVusing general (subtype-
independent) primers, as well as specific primers for thesubtypes 16 and 18. Except for one sample, all 60 samples
examined were found positive for HPV. To control against
artifacts in the PCR protocol, several controls were included
in the experiments. We used a positive and a negative control
for each of the HPV subtypes 16 and 18 to exclude the
possibility of false negative results. Furthermore, a known
HPV-negative paraffin-embedded tissue was processed on the
microtome along with the rest of the samples. This negative
control was treated in one batch with the rest of the samples
for DNA extraction, and then analyzed by PCR in a single
session. No PCR products were amplified in the negative
control, using either general or specific primers, although
a positive band was obtained with b-globin primers, confirm-
ing efficient DNA extraction, and excluding contamination-
generated artifacts (Figure 1).
Worldwide, HPV prevalence in cervical carcinoma is
reported to be 99.7%.12 Prevalence of HPV in Pakistani
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of 60 cervical carcinoma specimens were found positive for
HPV. Ubiquity of HPV subtype 16 in cervical carcinoma
may reflect a genetic and racial susceptibility of Pakistani
women to this particular subtype. In India, too, a high
prevalence of HPV16 has been reported among women.13
Since the Pakistani population shares its ancestral roots with
India, it is possible that the similarity in genetic makeup has
translated into a similar host response towards HPV infection.
It is very likely a genetically-determined, host-driven phe-
nomenon that favors propagation of subtype 16 in the Pakis-
tani population.
Our results underscore the importance of screening for
STIs in the asymptomatic Pakistani population. Although
reports in the past have suggested that Muslim women are
less susceptible to HPV infection,14 a recent study from
India has shown no difference between levels of suscept-
ibility for HPV among Muslim and non-Muslim women.15 Our
study supports the latter observation. Historically, screen-
ing for STIs has never been considered important in Muslim
countries, under the assumption that sexual promiscuity,
and therefore sexually transmitted disease, in a Muslim
population is nonexistent. The gravity of this matter is
further aggravated by the socio-cultural taboos that pro-
hibit investigation of all matters pertaining to sex and STIs.
In certain countries including Pakistan, where religious and
cultural values strictly discourage sexual promiscuity, pro-
tection from sexually transmitted infections, such as HPV, is
taken for granted. It is for this reason that on a national
level, the need to screen for STIs and increase public
awareness about the same has never been identified. Con-
sequently, hospitals and other healthcare facilities in Paki-
stan do not routinely prescribe HPV screening to female
patients. It is not common practice to perform Pap smears
on Pakistani women. As a result, the frequency of HPV
occurrence in the female Pakistani population is virtually
unknown.
The results of our study indicate that sexual non-promis-
cuity in Pakistani society could well be amyth. Although HPV
is not always spread through sexual intercourse,16 it does
appear to be the predominant mode of transmission. The
fact that nearly all cervical carcinoma patients were found
positive for HPV could mean that either the patients or their
partners had engaged in unsafe and/or extramarital sexual
activity. In that case, there is a possibility of other STIs being
present as well. This calls for efforts to be invested into
improving awareness among men and women, particularly
those socio-economically disadvantaged, about safe sexual
practices that decrease the risk of contracting STIs. Redu-
cing the overall occurrence of STIs could potentially
decrease HPV infection and, consequently, the incidence
of cervical carcinoma.
The socio-cultural taboos on sex become a major barrier
in establishing the epidemiology of HPV in Pakistan. Due to
their lack of awareness, people do not get screened for
STIs. Due to the stigma attached to sexual diseases, people
also choose not have their STI status diagnosed. Our results
highlight the need for regular cervical carcinoma screening
in asymptomatic Pakistani adult females. To date, cervical
carcinoma screening tools used in research on Pakistani
women include Pap smears to look for dyskaryosis and
visual inspection of the cervix using acetic acid.17 Sinceour study has confirmed a strong association of HPV with
cervical carcinoma, HPV typing can be used as a very
effective screening tool for cervical carcinoma in Pakistan.
Early detection of infection with a high-risk subtype
could give the patient an opportunity for more effective
management of the disease, as early treatment of HPV
infection has been shown to reduce the progression to
malignancy.18
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